News
Why Did The Clovis (CLVS) Stock Rise By 15% In Pre-Market Session?
Following an insolvency filing by the biopharmaceutical company on the previous day Wednesday, Clovis Oncology Inc. (NASD: CLVS) has increased 15.02%
Menu
Following an insolvency filing by the biopharmaceutical company on the previous day Wednesday, Clovis Oncology Inc. (NASD: CLVS) has increased 15.02%